secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001493152-23-004311
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imunon's EVP and CMO Nicholas Borys to depart Feb 28, 2023
----------------------------------------------------------

- Nicholas Borys, EVP and Chief Medical Officer, will separate effective February 28, 2023.
- Borys will receive salary continuation and COBRA premiums for up to 12 months; benefits cease or reduce if new employment is found.
- No replacement for the CMO role has been announced at this time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315223004311/0001493152-23-004311-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315223004311/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-004311

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer